CytomX Therapeutics, Inc. (CTMX)
NASDAQ: CTMX · Real-Time Price · USD
1.090
-0.010 (-0.91%)
At close: Dec 20, 2024, 4:00 PM
1.067
-0.023 (-2.11%)
After-hours: Dec 20, 2024, 6:50 PM EST
CytomX Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Dec '24 Dec 20, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 85 | 104 | 106 | 283 | 303 | 378 | |
| Market Cap Growth | 7.02% | -1.80% | -62.58% | -6.69% | -19.81% | -44.44% | |
| Enterprise Value | -22 | -75 | -70 | 69 | 7 | 80 | |
| Last Close Price | 1.09 | 1.55 | 1.60 | 4.33 | 6.55 | 8.31 | |
| Forward PE | - | 16.30 | - | - | - | - | |
| PS Ratio | 0.72 | 1.03 | 1.99 | 7.57 | 4.42 | 14.03 | |
| PB Ratio | -3.93 | -2.19 | -1.23 | -615.53 | -38.95 | 7.39 | |
| P/TBV Ratio | - | - | - | - | - | 7.73 | |
| P/FCF Ratio | - | - | - | - | 102.63 | - | |
| P/OCF Ratio | - | - | - | - | 57.57 | - | |
| EV/Sales Ratio | - | - | - | 1.84 | 0.11 | 2.98 | |
| EV/FCF Ratio | - | - | - | - | 2.48 | - | |
| Debt / Equity Ratio | -0.45 | -0.29 | -0.21 | -47.22 | -3.20 | 0.54 | |
| Debt / FCF Ratio | - | - | - | - | 8.43 | - | |
| Asset Turnover | 0.70 | 0.44 | 0.18 | 0.11 | 0.20 | 0.07 | |
| Quick Ratio | 1.01 | 1.14 | 1.50 | 3.93 | 4.65 | 3.46 | |
| Current Ratio | 1.04 | 1.17 | 1.55 | 3.98 | 4.76 | 3.54 | |
| Return on Equity (ROE) | - | - | - | - | -299.13% | -145.96% | |
| Return on Assets (ROA) | 2.33% | -1.75% | -19.54% | -20.78% | -14.38% | -22.15% | |
| Return on Capital (ROIC) | - | - | - | -378.62% | -104.99% | -84.35% | |
| Earnings Yield | 16.21% | -0.55% | -93.93% | -41.01% | -21.41% | -35.18% | |
| FCF Yield | -104.08% | -54.78% | -106.42% | -42.70% | 0.97% | -38.13% | |
| Buyback Yield / Dilution | -19.68% | -12.27% | -2.48% | -39.01% | -1.79% | -8.81% | |
| Total Shareholder Return | -19.68% | -12.27% | -2.48% | -39.01% | -1.79% | -8.81% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.